COVID-19 Pandemic: Prevention and Protection Measures to Be Adopted at the Workplace
暂无分享,去创建一个
Caterina Ledda | Venerando Rapisarda | Fulvio Plescia | V. Rapisarda | C. Ledda | E. Cannizzaro | L. Cirrincione | F. Plescia | Emanuele Cannizzaro | Luigi Cirrincione | Daniela Martorana | Raluca Emilia Moldovan | Kelly Theodoridou | Daniela Martorana | R. Moldovan | K. Theodoridou | Raluca Moldovan | Kelly Theodoridou
[1] Lisa E. Gralinski,et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.
[2] D. J. Weber,et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination☆ , 2015, Journal of Hospital Infection.
[3] James O. Lloyd-Smith,et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 , 2020, medRxiv.
[4] F. Kilinc. A Review of Isolation Gowns in Healthcare: Fabric and Gown Properties , 2015, Journal of engineered fibers and fabrics.
[5] L. Gostin,et al. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.
[6] Z. Memish,et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China , 2020, International Journal of Infectious Diseases.
[7] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[8] Y. Furuta,et al. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase , 2017, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[9] Xiaotao Lu,et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease , 2018, mBio.
[10] J. Nie,et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.
[11] Yuguo Li,et al. Recognition of aerosol transmission of infectious agents: a commentary , 2019, BMC Infectious Diseases.
[12] Tiziana Ramaci,et al. Night-Time Shift Work and Related Stress Responses: A Study on Security Guards , 2020, International journal of environmental research and public health.
[13] R. Wunderink,et al. MERS, SARS and other coronaviruses as causes of pneumonia , 2017, Respirology.
[14] D. Anderson,et al. Assessment of Self-Contamination During Removal of Personal Protective Equipment for Ebola Patient Care , 2016, Infection Control & Hospital Epidemiology.
[15] Bo Li,et al. Insights into the cross-species evolution of 2019 novel coronavirus , 2020, Journal of Infection.
[16] D. Batlle,et al. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? , 2020, Clinical science.
[17] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[18] Joy Y. Feng,et al. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus , 2020, The Journal of Biological Chemistry.
[19] P. Teunis,et al. Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population , 2008, PloS one.
[20] R. Baric,et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.
[21] Xiaohu Zheng,et al. Effective treatment of severe COVID-19 patients with tocilizumab , 2020, Proceedings of the National Academy of Sciences.
[22] Hyeshik Chang,et al. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) , 2020, Experimental neurobiology.
[23] J. Peiris,et al. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus , 2011, Advances in virology.
[24] William A. Lee,et al. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses , 2017, Journal of medicinal chemistry.
[25] Novel Coronavirus Pneumonia Emergency Response Epidemiol Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[26] Dylan H. Morris,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.
[27] Jianjun Gao,et al. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. , 2020, Bioscience trends.
[28] Sheng-Qun Deng,et al. Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China , 2020, Journal of clinical medicine.
[29] B. Cowling,et al. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. , 2019, Current opinion in infectious diseases.
[30] Biao Ren,et al. Transmission routes of 2019-nCoV and controls in dental practice , 2020, International Journal of Oral Science.
[31] L. Hong,et al. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019. , 2020, European review for medical and pharmacological sciences.
[32] Shibo Jiang,et al. The spike protein of SARS-CoV — a target for vaccine and therapeutic development , 2009, Nature Reviews Microbiology.
[33] T. Singhal. A Review of Coronavirus Disease-2019 (COVID-19) , 2020, The Indian Journal of Pediatrics.
[34] A. Arvey,et al. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses , 2017, Scientific Reports.
[35] Christopher M Walker,et al. Effect of ultraviolet germicidal irradiation on viral aerosols. , 2007, Environmental science & technology.
[36] J. Verbeek,et al. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. , 2016, The Cochrane database of systematic reviews.
[37] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[38] B. Cowling,et al. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. , 2019, Current opinion in infectious diseases.
[39] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[40] G. Kampf,et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents , 2020, Journal of Hospital Infection.
[41] Tiina Reponen,et al. Respiratory Performance Offered by N95 Respirators and Surgical Masks: Human Subject Evaluation with NaCl Aerosol Representing Bacterial and Viral Particle Size Range , 2008, The Annals of occupational hygiene.
[42] D. Batlle,et al. Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System , 2019, Biomolecules.
[43] D. Wang,et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.
[44] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[45] Tiziana Ramaci,et al. Work-Related Stress, Physio-Pathological Mechanisms, and the Influence of Environmental Genetic Factors , 2019, International journal of environmental research and public health.
[46] M Q Zhang,et al. [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
[47] Guozhong He,et al. Potential Factors Influencing Repeated SARS Outbreaks in China , 2020, International journal of environmental research and public health.
[48] Xu Liu,et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] N. White,et al. The treatment of malaria. , 1996, The New England journal of medicine.
[50] J. Penninger,et al. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[51] B. Crook,et al. Effectiveness of surgical masks against influenza bioaerosols. , 2013, The Journal of hospital infection.
[52] William A. Lee,et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys , 2016, Nature.
[53] J. Garcia,et al. Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia‐induced pulmonary hypertension , 2017, British journal of pharmacology.
[54] Frank Grosveld,et al. A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.
[55] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[56] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[57] Federico M Giorgi,et al. Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.
[58] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).